Murthy Vedam Rama, Raghuram Donkena Venkata, Murthy Pirala Narayana
T. J. P. S College, Guntur, Andhra Pradesh, India.
Bioinformation. 2007 May 20;2(1):12-6. doi: 10.6026/97320630002012.
Studies pertaining to drug-DNA interactions in treating a disease efficiently have taken an important place in recent times. Murthy and colleagues were active in correlating the drug activity, with physical parameters like refractivity, susceptibility, molecular electron ionization cross-section and the dosage. The molecular polarizability, diamagnetic susceptibility and molecular electron ionization cross section Q have been evaluated. An analysis of Q in the light of the data available on plasma protein binding, bio availability, Log P and half-Life show semblance of regular dependence of Q on them and hence an effort is made to bring this dependence into a regular mathematical relationship. The dosage of each drug is calculated. A critical look at the results arrived on Q and dosages reveal that a highly active drug with large Q need to be monitored in very small quantities and any minute increase in dosage is resulting in unwanted toxic effects and vice versa. The algebraic formulae enable one to calculate the dosages theoretically from the value of Q and other parameters and the calculated dosage through the formulae agreed favorably well with suggested dosages. For example, in primaquine phosphate, the calculated dosage is 30 mg per day against the suggested practical dosage of 26.3 mg per day. A similar observation is made in mepacrine with theoretical dosage of 60 mg per day as against the suggested practical dosage of 100 mg per day. In short, the molecular structure followed by refraction and susceptibility measurements and Q will throw light on dosage, toxicity of a drug. Thus the present investigations pave way for a new direction of approach for study of drug activity without recourse to techniques involving highly expensive instrumentation and highly theoretical approaches involving quantum mechanical methods.
近年来,有关药物与DNA相互作用以有效治疗疾病的研究占据了重要地位。穆尔蒂及其同事积极将药物活性与诸如折射率、磁化率、分子电子电离截面和剂量等物理参数相关联。已经评估了分子极化率、抗磁磁化率和分子电子电离截面Q。根据血浆蛋白结合、生物利用度、脂水分配系数(Log P)和半衰期的现有数据对Q进行分析,结果表明Q与这些参数之间存在明显的规律性依赖关系,因此人们努力将这种依赖关系转化为规则的数学关系。计算每种药物的剂量。对基于Q和剂量得出的结果进行批判性审视后发现,具有大Q值的高活性药物需要以非常小的剂量进行监测,剂量的任何微小增加都会导致不良毒性作用,反之亦然。这些代数公式使人们能够从Q值和其他参数理论上计算剂量,并且通过公式计算出的剂量与建议剂量非常吻合。例如,对于磷酸伯氨喹,计算出的剂量为每天30毫克,而建议的实际剂量为每天26.3毫克。在阿的平方面也有类似的观察结果,理论剂量为每天60毫克,而建议的实际剂量为每天100毫克。简而言之,通过分子结构,再结合折射和磁化率测量以及Q值,将能够阐明药物的剂量和毒性。因此,目前的研究为研究药物活性开辟了一个新的方向,无需借助涉及高成本仪器的技术以及涉及量子力学方法的高度理论性方法。